John Hussman's INDV Position Overview
John Hussman (via Hussman Strategic Advisors, Inc.) currently holds 42,000 shares of Indivior Pharmaceuticals, Inc. (INDV) worth $1.51 M, representing 0.32% of the portfolio. First purchased in 2026-Q3, this recently established position has been held for 1 quarters.
Based on recent 13F filings, John Hussman has initiated a new position in INDV, representing a fresh investment thesis on this company. Insufficient history to summarize additions or reductions.
Analysis based on 13F filings available since 2013 Q2
John Hussman's Indivior Pharmaceuticals (INDV) Holding Value Over Time
Track share changes against reported price movement
Quarterly Indivior Pharmaceuticals (INDV) Trades by John Hussman
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q3 2026 | +42,000 | New Buy | 42,000 | $35.85 |
John Hussman's Indivior Pharmaceuticals Investment FAQs
John Hussman first purchased Indivior Pharmaceuticals, Inc. (INDV) in Q3 2026, acquiring 42,000 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
John Hussman has held Indivior Pharmaceuticals, Inc. (INDV) for 1 quarters since Q3 2026.
John Hussman's largest addition to Indivior Pharmaceuticals, Inc. (INDV) was in Q3 2026, adding 42,000 shares worth $1.51 M.
According to the latest 13F filing for Q3 2026, John Hussman's firm, Hussman Strategic Advisors, Inc., owns 42,000 shares of Indivior Pharmaceuticals, Inc. (INDV), valued at approximately $1.51 M.
As of the Q3 2026 filing, Indivior Pharmaceuticals, Inc. (INDV) represents approximately 0.32% of John Hussman's publicly disclosed stock portfolio, making it one of their key holdings.
John Hussman's peak holding in Indivior Pharmaceuticals, Inc. (INDV) was 42,000 shares, as reported at the end of Q3 2026.